Introduction
Transforming growth factor-b (TGF-b) superfamily of extracellular growth factors regulate cell proliferation, differentiation, apoptosis and morphogenesis (Shi and Massague, 2003) . Upon ligand binding to two different types of serine/threonine kinase receptors, type I receptor is activated by type II receptor and transduces intracellular signals by phosphorylation of Smad proteins. Smad proteins are classified into three groups, that is, receptor-regulated Smad (R-Smad), common partner Smad (Co-Smad) and inhibitory Smad (I-Smad). Smad1, 5 and 8 are phosphorylated by the bone morphogenetic protein (BMP) receptors, whereas Smad2 and 3 are phosphorylated by the TGF-b/activin receptors. Phosphorylated R-Smad forms a functional signaling complex with Smad4 (Co-Smad) and translocates into the nucleus to regulate expression of the ligand-responsive genes .
TGF-b regulates a number of genes in a cell-type-and context-dependent manner. For example, TGF-b stimulates the expression of plasminogen activator inhibitor-1 (PAI-1) and Smad7 (Pepper et al., 1990; Nakao et al., 1997) . Activated Smad complexes directly bind to 'CAGA' or related DNA sequences of their promoters and recruit transcriptional coactivators, such as p300/ CBP (Dennler et al., 1998; Nagarajan et al., 1999) . In contrast, TGF-b is also known to downregulate some genes, such as c-myc (Pietenpol et al., 1990) . Activated Smad complex binds to TGF-b1 inhibitory element (TIE) on the c-myc promoter and represses the transcription of c-myc (Kerr et al., 1990; Chen et al., 2001 Chen et al., , 2002 Yagi et al., 2002) . Furthermore, R-SmadCo-Smad heteromers interact with various transcriptional factors and regulate a wide variety of intracellular signals in target cells (Miyazawa et al., 2002) .
c-Myc plays a central role in cell growth control in TGF-b signaling. In the absence of TGF-b, c-Myc forms heterodimers with Miz-1 and represses the transcription of cyclin-dependent kinase inhibitors, p15/Ink4b and p21/Waf1/Cip1 Staller et al., 2001) . TGF-b rapidly reduces the c-myc transcription, resulting in the stimulation of the expression of p15/Ink4b and p21/Waf1/Cip1 and cell cycle arrest in the G1 phase. Thus, TGF-b-induced-downregulation of c-myc is an upstream and critical event in growth inhibition by TGF-b. A recent study demonstrated that TGF-binduced nuclear translocation of the Smad3/4-E2F4/5-DP1-p107 complex is important in repression of c-myc transcription (Chen et al., 2002) .
The Ski family of nuclear oncoproteins represses TGF-b signaling through interactions with the Smad proteins (Akiyoshi et al., 1999; Luo et al., 1999; Stroschein et al., 1999; Sun et al., 1999) . c-Ski interacts with R-Smad and Co-Smad at different regions and was reported to disrupt an active Smad heteromeric complex, composed of Smad2 and 4 (Wu et al., 2002) . The mechanism of Ski-mediated repression of TGF-b signaling has been primarily attributed to transcriptional modulation, through recruitment of the nuclear co-repressor (N-CoR) and histone deacetylase complex (HDAC), as well as interference of Smadmediated binding to the transcriptional coactivator p300/CBP (Akiyoshi et al., 1999; Wu et al., 2002) . These mechanisms explain how c-Ski represses the transcriptional activity of Smads; however, it is not clear how c-Ski inhibits Smad-induced transcriptional repression of some target genes including c-myc (Sun et al., 1999) .
Here, we investigated the mechanism of c-Skimediated inhibition of TGF-b signaling and found that c-Ski enhances the binding of Smad complex on DNA. This enhancement of Smad binding on DNA by c-Ski requires interaction with Smad4, but not with Smad2. These results provide a novel mechanism for c-Skimediated inhibition of Smad-induced transcriptional activation and repression.
Results

Establishment of c-Ski transfectants from human keratinocyte HaCaT cells
To examine the role of c-Ski on TGF-b signaling, we established HaCaT cells that stably expressed FLAGtagged c-Ski. We obtained two transfectants (clone 2 and 14) that expressed c-Ski at similar levels. The expression levels of c-Myc and Smad2/3 were similar between mock and c-Ski transfected cells (Figure 1a) .
We next examined the binding between Smads and cSki in these cell lines. Smad2/3 bound to c-Ski in a TGFb-dependent manner, and in contrast to the data shown by Prunier et al. (2003) phosphorylation of Smad2 was hardly inhibited in c-Ski-transfected cells (Figure 1b) . These results suggest that the action of c-Ski could not be primarily attributed to inhibition of R-Smad phosphorylation in HaCaT cells. Smad4 bound to Smad2/3 in a TGF-b-dependent manner, whereas it bound to c-Ski in a TGF-bindependent manner (Figure 1c ). c-Ski bound to phosphorylated Smad2 (Figure 1d ). Nuclear translocation of Smad2/3 by TGF-b was not affected in these cell lines (data not shown). These results indicated that c-Ski binds to Smad4 in the absence of TGF-b stimulation and to phosphorylated Smad2 upon stimulation with TGF-b. We next investigated transcriptional activity induced by TGF-b using the (CAGA) 9 MLP-luc construct in these cell lines. Consistent with the previous observations (Akiyoshi et al., 1999) , the activation of (CAGA) 9 MLP-luc induced by TGF-b was inhibited in c-Ski-transfected cells (Figure 1e ). Previously, we and other groups identified a Smadbinding element on the c-myc promoter (TIE) (Chen et al., , 2002 Yagi et al., 2002) . Smad2 and 3 bind to the TIE, which is important in TGF-b-induced downregulation of c-myc promoter activity. Therefore, we examined the c-myc promoter activity in c-Skitransfected cells. The transcriptional repression of 3 Â TIE-lux by TGF-b was also inhibited in c-Skitransfected cells (Figure 2c ). However, this inhibition is partial, which is consistent with the observation that cmyc mRNA reduction was partially inhibited in c-Ski transfectants ( Figure 2a ). Mink lung epithelial Mv1Lu cells are also sensitive to TGF-b-induced growth inhibition. We next examined the effect of c-Ski on cmyc promoter activity by transient transfection using Mv1Lu cells. Figure 2d shows that c-Ski inhibited the TGF-b-induced downregulation of 3 Â TIE activity in a dose-dependent manner.
Acetylation of histone is important for gene activation. Accordingly, we examined the histone acetylation status near the c-myc promoter region in the presence of TGF-b by chromatin immunoprecipitation (CHIP). Histone H3 acetylation of the c-myc promoter (including TIE) in mock-transfected cells was reduced by treatment with TGF-b for 1 h. However, in c-Skitransfected cells, histone H3 acetylation of c-myc promoter was not reduced by TGF-b (Figure 2e ). These results indicated that c-Ski inhibits both TGF-b-induced transcriptional activation (CAGA) and repression (TIE).
Enhanced binding of Smad2 and 4 to both TIE and CAGA probes in c-Ski-transfected cells c-Ski has been reported to bind to the Smad binding element (SBE) that contains a CAGA sequence, in a Smad-dependent manner (Akiyoshi et al., 1999) . We next examined the binding of Smad2, 3 and c-Ski on 3 Â CAGA and 3 Â TIE probes by DNA-affinity precipitation (DNAP). As shown in Figure 3a , Smad2 and 3 bound to these probes in mock-transfected cells by treatment with TGF-b. However, Smad2 binding to these probes in c-Ski-transfected cells was enhanced compared with that seen in mock-transfected cells. Binding of Smad4 was also enhanced in c-Ski-transfected cells. Furthermore, binding of c-Ski to these probes correlated with that of Smads, especially on the 3 Â TIE probe (Figure 3a) .
We next studied the DNA binding of Smad and c-Ski in COS-7 cells transiently transfected with various cDNA, as shown in Figure 3b . In the presence of constitutively active TGF-b type I receptor (ALK5 (TD)), Smad2 bound weakly to DNA probes, because Smad2 has a region which inhibits direct binding to ) for 1 h and cell lysates from mock-and c-Ski-transfected cells were subjected to DNAP using biotinylated 3 Â CAGA or 3 Â TIE as probes. Immunoblot analysis was performed using anti-Smad2/3, Smad4 and FLAG antibodies. (b,c) COS-7 cells were transfected as indicated. Cell lysates were subjected to DNAP as described above. Immunoblot analysis was performed using anti-FLAG antibody Stabilization of Smad complexes on DNA by c-Ski H Suzuki et al DNA (Yagi et al., 1999) . However, when c-Ski was cotransfected with Smad2 and 4, binding of Smad2 and 4 to DNA was markedly enhanced. Enhancement of the DNA binding of Smad3 and 4 by c-Ski was weak compared with that of Smad2 and 4. Furthermore, enhancement of DNA binding of either Smad2-4 or Smad3-4 by c-Ski was observed in the absence of ALK5 (TD). Similar results were obtained by cells cotransfected with SnoN, another member of the Ski family oncoproteins (Figure 3c ).
Smad4-binding ability of c-Ski is important for the enhancement of DNA-binding activity of Smad complex
To investigate the requirement of Smads for c-Skimediated enhancement of DNA binding, we transfected different combinations of Smads with c-Ski (Figure 4a ). When only Smad2 was co-transfected with c-Ski, enhancement of DNA binding of Smad2 was weak. However, when Smad2 and 4 were transfected with cSki, DNA binding of both Smad2 and 4 was markedly enhanced (Figure 4a, lanes 1-4) . In contrast, enhancement of DNA binding of Smad3 by c-Ski was not marked in either the presence or absence of Smad4 (lanes 5-8). When only Smad4 was transfected with cSki, DNA binding of Smad4 was still enhanced by c-Ski (lanes 9-11).
c-Ski was reported to interact with Smad2/3 and 4 at different regions. c-Ski D2/3 (aa 24-728) interacts with Smad4 but not with Smad2/3, and c-Ski W274E interacts with Smad2/3 but not with Smad4. c-Ski D2/3 W274E does not bind to either Smad2/3 or 4 (Wu et al., 2002) . Using these mutants, we examined their effects on the DNA-binding ability of Smad2 and 4 (Figure 4b ). Wild-type c-Ski (c-Ski WT) and c-Ski D2/3 enhanced the binding of Smad2 and 4 to TIE and CAGA probes, but c-Ski W274E did not (Figure 4b,  lanes 1-5) . Although c-Ski WT and c-Ski W274E bind to Smad2, they did not enhance the binding of Smad2 to DNA in the absence of Smad4 (lanes 6-10). In contrast, c-Ski WT and c-Ski D2/3, which bind to Smad4, enhanced the DNA binding of Smad4 (lanes 11-15). These results indicated that c-Ski enhances the DNA-binding ability of Smad4, but not that of Smad2. c-Ski mutants including c-Ski W274E did not affect the DNA-binding ability of the Smad3-4 complex, although they interacted with the Smad complex (Figure 4c ). 
Effects of c-Ski mutants on the TGF-b responsive promoter
To investigate the functional importance of c-Skimediated enhancement of DNA binding by Smad complex, we performed luciferase reporter assays using c-Ski mutants. Here we used ARE-lux and p3TP-lux reporters, which are preferentially activated by Smad2 and 3, respectively. As shown in Figure 5a , c-Ski WT and D2/3, but not c-Ski W274E, inhibited the activation of ARE-lux by ALK5 (TD). Expression of these mutants was similar (Figure 5a, lower panel) . In contrast, c-Ski WT, D2/3 and W274E inhibited the activation of p3TP-lux by ALK5 (TD) (Figure 5b ), which was in agreement with our recent finding (Takeda et al., 2004) , where (CAGA) 9 MLP-luc was used. These results indicated that overexpression of c-Ski W274E inhibits the activation of p3TP-lux, but not ARE-lux.
Discussion
Wu et al. (2002) reported that c-Ski disrupts the interaction between phospho-Smad2 and 4, and prevents the formation of a functional complex between R-Smad and Smad4. In this study, we found that c-Ski enhances the binding of Smad2-4 complex to DNA (Figures 3 and 4) . The enhancement of the DNAbinding ability of Smad complex by c-Ski was also found in the absence of constitutively active TGF-b type I receptor (Figure 3b ), suggesting that c-Ski has a strong activity to assemble R-and Co-Smads on DNA, which is independent of phosphorylation of R-Smad by type I receptors. In intact cells, however, c-Ski forms a complex with phospho-R-Smad and Co-Smad (Figure 1d) . It is well known that activated Smad complexes are involved in transcriptional activation or repression, which is dependent on the target genes. For example, Smad3 and 4 bind to CAGA and CAGA-related sequences and transactivate genes such as Smad7 (Nagarajan et al., 1999) . c-Ski can act as a transcriptional co-repressor due to multiple direct and indirect interaction with histone deacetylase complexes containing N-CoR/SMART and Sin3 (Nomura et al., 1999) . However, a c-Ski mutant that fails to interact with NCoR can inhibit TGF-b signaling (Ueki and Hayman, 2003a) , suggesting that a N-CoR-independent mechanism may also play a role in the inhibition of TGF-b signaling by c-Ski. These results and our present findings suggested that c-Ski inhibits the Smad-responsive promoters through multiple mechanisms, including (1) deacetylation of histone and (2) stabilization of Smad complex on DNA, which inhibits the access of newly activated Smad complex to SBE (Figure 6a and b) .
In addition, it has been reported that a Smad3/4-E2F4/5-DP1-p107 complex binds to TIE and represses the transcription of c-myc (Chen et al., 2002) . The enhancement of the DNA-binding ability of Smad complex by c-Ski was observed in TIE as well as in CAGA (Figures 3 and 4) . It is not clear whether c-Ski affects the formation of Smad3/4-E2F4/5-DP1-p107 complex. Since Smad3 can directly bind to this element in the absence of other factors (Yagi et al., 2002) , the binding of Smad3/4-E2F4/5-DP1-p107 complex to TIE may be inhibited by the formation of stable c-SkiSmad complex on this element (Figure 6c and d) . Histone H3 acetylation of c-myc promoter (including TIE) was not reduced in c-Ski-transfected cells (Figure 2e ), indicating that c-Ski does not affect the histone acetylation around TIE. Wu et al. (2002) identified the SAND domain-like motif (I-loop) of Ski as a Smad4-binding domain. The SAND domain represents a large family of DNAbinding motifs present in transcription factors and other nuclear proteins. We found that a c-Ski mutant within I-loop, which cannot bind to Smad4, failed to enhance the DNA binding of Smad4 (Figure 4b ). It is not clear whether c-Ski enhances the DNA-binding ability of Smad4, or whether the DNA-binding ability of the I-loop is acquired through the interaction with Smad4. We cannot rule out the possibility that another domain of c-Ski may be involved in the enhancement of DNA binding of Smad4. Although the enhancement of Smad binding to DNA did not require binding between Smad2/3 and c-Ski (Figure 4b ), the formation of R-and Co-Smad hetero-oligomer is required for the recognition of SBE. Therefore, the R-and Co-Smad Although Wu et al. (2002) proposed a model that cSki interferes with the direct association between phospho-R-Smad and Co-Smad, two recent reports including ours challenged the model (Ueki and Hayman, 2003b; Takeda et al., 2004) ; c-Ski as well as c-Ski mutants lacking R-Smad-binding or Smad4-binding ability interacted with the phospho-R-Smad-Co-Smad complex without disrupting their direct association. In either event, it is possible that c-Ski binding somehow inactivates R-Smad-Co-Smad complex, and the nonfunctional Smad complex has high affinity to SBE. In this respect, it is noteworthy that c-Ski W274E inhibited p3TP-lux but not ARE-lux ( Figure 5 ). Smad3 is mainly involved in the activation of p3TP-lux because Smad3-deficient fibroblasts failed to activate the reporter (Piek et al., 2001) and Smad2 is thought to play a more important role than Smad3 in the activation of ARE-lux (Labbe et al., 1998) . c-Ski W274E interacts with Smad3-4 complex (Takeda et al., 2004) and Smad3-Smad4-c-Ski W274E complex has high affinity to the CAGA or TIE element (Figure 4c ). In contrast, although c-Ski W274E interacts with Smad2-4 complex (Wu et al., 2002) , Smad2-4-c-Ski W274E complex has very low affinity to the DNA elements (Figure 4b) . Thus, binding of c-Ski to Smad complex is not enough to suppress Smad signaling; high-affinity binding of c-Ski-Smad complex to the DNA elements appears to be an essential process in c-Ski-mediated suppression of Smad signaling. As Smad3-4 complex has high affinity to the DNA elements and is active in transcriptional activation, some additional process is likely to be involved in the inactivation of Smad complex, which remains to be elucidated. If disruption of the phospho-R-Smad-CoSmad complex is the sole mechanism of c-Ski-mediated suppression, an equal amount of c-Ski to Smad complexes will be required. In our model described in Figure 6 , c-Ski stabilizes and inactivates the Smad complex on SBE, the number of which is presumably less than that of activated Smad complex. It may be effective to inhibit large numbers of activated Smad complexes with small numbers of c-Ski.
How is c-Ski-Smad complex removed from DNA? It has been reported that SnoN is ubiquitinated by E3 ubiquitin ligase Smurf2, or anaphase-promoting complex, via Smad2 and 3, respectively Stroschein et al., 2001) . c-Ski is also ubiquitinated by Smurf2 (Mizuide et al., 2003) . These mechanisms may contribute to negative regulation of c-Ski-mediated inhibition of Smad by removing c-Ski-Smad complex from DNA.
In summary, we found that c-Ski inhibits Smadmediated transcriptional regulation through the stabilization of inactive Smad complex on SBE. Our findings provide a novel insight into the transcriptional regulation of Ski family oncopropteins.
Materials and methods
Cells
Mv1Lu, 293T and COS7 cells were obtained from the American Type Culture Collection. R-mutant Mv1Lu cells were from Drs M Laiho and J Massague´. These cells were cultured in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% fetal bovine serum (FBS) and 10 mg/ ml gentamicin. HaCaT cells stably expressing FLAG-c-Ski were maintained in MCDB153 medium (Sigma) supplemented with 0.1 mM calcium chloride, 10 ng/ml epidermal growth factor, 10 mg/ml gentamicin, 300 mg/ml G418 (Gibco Life Technologies) and 5% dialysed FBS. 
DNA constructs
c-myc cDNA was provided by Drs B Blackwood and RN Eisenman. Expression constructs encoding ALK5 (TD), FLAG-Smads, FLAG-c-SnoN and FLAG-c-Ski were described previously (Akiyoshi et al., 1999) . c-Ski mutants were generated using a PCR-based method. (CAGA) 9 MLP-luc and 3 Â TIE/E2F-lux were described previously (Dennler et al., 1998; Yagi et al., 2002) .
Northern blot analysis
Total cellular RNA was extracted using Isogen (Nippongene) following the manufacturer's recommendations. In all, 20 mg aliquots were electrophoresed on 1% agarose-formaldehyde gels and transferred to nylon membrane (Biodyne A, Pall BioSupport Co.). The membranes were hybridized at 421C overnight with randomly primed DNA probes labeled with [a-32 P] dCTP in a hybridization buffer containing 5 Â SSC, 25% formamide, 1% SDS, 5 Â Denhardt's solution, and 0.2 mg/ml denatured salmon testis DNA. The membranes were washed to a final stringency of 0.1 Â SSC, 0.1% SDS at 651C, and analysed using a Fuji BAS 2500 Bio-Image Analyzer (Fuji Photo Film) and autoradiography.
Immunoprecipitation and immunoblotting
Total cell extract for immunoblotting was prepared as previously described (Suzuki et al., 2001) . For immunoprecipitation, cells were solubilized in a buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 1.5% Trasylol and 1 mM phenylmethylsulfonyl fluoride (PMSF). After clearing with centrifugation, total cell lysates or immunoprecipitates obtained using indicated antibodies were subjected to SDS-PAGE. Proteins were electrotransferred to PVDF membranes (ProBlott, Applied Biosystems) and subjected to immunoblotting. Anti-Myc (9E10, Calbiochem), antihemagglutinin (HA) (3F10, Roche), anti-FLAG (M2, Sigma), anti-Smad2/3 (clone 18, Transduction Laboratories), antiSmad4 (Santa Cruz) and anti-phospho-Smad2 (Upstate) antibodies were used as primary antibodies for immunoblotting. The reacted antibodies were detected using an enhanced chemiluminescence detection system (Amersham Pharmacia Biotech). For re-blotting, the membranes were stripped following the manufacturer's protocol.
Growth inhibition assay
Cells were seeded in 12-well plates at a density of 5 Â 10 4 cells per well and cultured for 24 h in the growth medium for each cell line. Cells were then treated with 100 pM of TGF-b (R&D Systems) for the indicated time points and cell number was counted by Coulter counter (Coulter).
DNA transfection and luciferase assay
Cells were transfected using FuGENE6 transfection reagent (Roche Diagnostics) following the manufacturer's recommendations. Stable HaCaT clones transfected with pcDNA3-FLAG-c-Ski were selected and maintained in the presence of 300 mg/ml G418. Luciferase activity in the cell lysates was determined by a dual luciferase reporter assay system (Promega) using a luminometer (AutoLumat LB953, EG & G Berthold). Luciferase activities were normalized to seapansy luciferase activity of co-transfected pRL-CMV (Promega).
DNAP
Cell lysates were prepared in 1% Nonidet P-40, 150 mM NaCl, 1 mM PMSF, 1.5% Trasylol and 20 mM Tris-HCl (pH 7.5). Equal amounts of proteins were precleared with streptavidinagarose beads (Sigma) and then incubated with 200 ng of biotinylated double-stranded oligonucleotides in the presence of 2 mg of poly (dI-dC) at 41C for 1 h. DNA-bound proteins were mixed with streptavidin-agarose for 1 h with end-overend rotation, washed extensively with cell lysis buffer, and analysed by SDS-PAGE and immunoblotting. The sequences of the 3 Â CAGA and 3 Â TIE probes were as described previously (Nishihara et al., 1999; Yagi et al., 2002) .
CHIP
CHIP was performed as previously described (Liu et al., 2001) , with modification. Cells were treated with 100 pM of TGF-b at 371C for 1 h. Following cross-linking with 1% HCHO at 371C for 20 min and two washes with phosphate-buffered saline (PBS), the cells were resuspended in 3 ml of TE supplemented with 1 mM PMSF and sonicated. Soluble chromatin was collected by centrifugation for 10 min at 13 kr.p.m. in a microfuge and adjusted to 0.1% SDS, 1% Triton X-100, 0.1% sodium deoxycholate and 140 mM NaCl (RIPA buffer). Immunoprecipitation reactions containing 1 ml of the chromatin, 25 ml of protein A sepharose beads and 1 ml of anthistone H3 antibody (Upstate) were incubated with rotation overnight at 41C. The immunoprecipitates were washed sequentially four times with RIPA buffer containing 0.3 M NaCl, once with RIPA buffer containing no NaCl, and once with TE. DNA was eluted by an elution buffer (10 mM DTT, 1% SDS, 0.1 M NaHCO 3 ). Following reverse crosslinking at 651C for 6 h, DNA was treated with proteinase K and purified using a PCR purification kit (Qiagen). DNA was eluted in 20 ml of TE, and 2.5 ml was used for PCR analysis. PCR primers were as described previously (Chen et al., 2002) .
